Cancer-Testis Antigens: -Smart- Biomarkers for Diagnosis and Prognosis of Prostate and Other CancersReportar como inadecuado


Cancer-Testis Antigens: -Smart- Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers


Cancer-Testis Antigens: -Smart- Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

1

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA

2

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA

3

Laboratory of New methods in Biology, Institute for Biological Instrumentation, Russian Academy of Sciences, Pushchino 142290, Moscow Region, Russia





*

Authors to whom correspondence should be addressed.



Academic Editor: Carsten Stephan

Abstract A clinical dilemma in the management of prostate cancer PCa is to distinguish men with aggressive disease who need definitive treatment from men who may not require immediate intervention. Accurate prediction of disease behavior is critical because radical treatment is associated with high morbidity. Here, we highlight the cancer-testis antigens CTAs as potential PCa biomarkers. The CTAs are a group of proteins that are typically restricted to the testis in the normal adult but are aberrantly expressed in several types of cancers. Interestingly, >90% of CTAs are predicted to belong to the realm of intrinsically disordered proteins IDPs, which do not have unique structures and exist as highly dynamic conformational ensembles, but are known to play important roles in several biological processes. Using prostate-associated gene 4 PAGE4 as an example of a disordered CTA, we highlight how IDP conformational dynamics may regulate phenotypic heterogeneity in PCa cells, and how it may be exploited both as a potential biomarker as well as a promising therapeutic target in PCa. We also discuss how in addition to intrinsic disorder and post-translational modifications, structural and functional variability induced in the CTAs by alternate splicing represents an important feature that might have different roles in different cancers. Although it is clear that significant additional work needs to be done in the outlined direction, this novel concept emphasizing multifunctionality as an important trait in selecting a biomarker underscoring the theranostic potential of CTAs that is latent in their structure or, more appropriately, the lack thereof, and casts them as next generation or -smart- biomarker candidates. View Full-Text

Keywords: biomarkers; prostate cancer; cancer-testis antigens; intrinsically disordered protein; prostate-associated gene 4 PAGE4; nucleolar protein 4 NOL4; centrosomal protein of 55 kDa CEP55 biomarkers; prostate cancer; cancer-testis antigens; intrinsically disordered protein; prostate-associated gene 4 PAGE4; nucleolar protein 4 NOL4; centrosomal protein of 55 kDa CEP55





Autor: Prakash Kulkarni 1,* and Vladimir N. Uversky 2,3,*

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados